NCT00652665

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

To Compare the Relative Bioavailability of Leflunomide 20mg Tablets (Kali) With That of ARAVA 20mg Tablets(Aventis) Under Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: Par Pharmaceutical, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To compare the single-dose Bioavailability of Kali and Aventis

Detailed description

To compare the relative Bioavailability of leflunomide 20mg tablets with that of ARAVA 20mg tablets in healthy, adult subjects under fasting conditions

Conditions

• To Determine the Bioequivalence Study Under Fasting

Interventions

Type	Name	Description
DRUG	Leflunomide	Tablets, 20mg, single-dose
DRUG	ARAVA	Tablets, 20mg,single-dose

Timeline

• Start date: 2003-06-01
• Primary completion: 2003-07-01
• Completion: 2003-07-01
• First posted: 2008-04-04
• Last updated: 2008-04-04